Pyrido[2,1-a]isoquinoline derivatives
US6897222B2 · kind B2 · utility
16Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2004 |
| Grant date | May 24, 2005 |
| Priority date | — |
| Expiry date | Mar 15, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I): wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.